key: cord-0909441-eh094o0x authors: Gan, Y.; Du, L.; Damola, F. O.; Huang, J.; Xiao, G.; Lyu, X. title: Sample Pooling as a Strategy of SARS-COV-2 Nucleic Acid Screening Increases the False-negative Rate date: 2020-05-26 journal: nan DOI: 10.1101/2020.05.18.20106138 sha: 337bbdfeabaedd15ba04cbfb67c39c92a8d7df8d doc_id: 909441 cord_uid: eh094o0x Identification of less costly and accurate methods for monitoring novel coronavirus disease 2019 (CoViD-19) transmission has attracted much interest in recent times. Here, we evaluated a pooling method to determine if this could improve screening efficiency and reduce costs while maintaining accuracy in Guangzhou, China. We evaluated 8097 throat swap samples collected from individuals who came for a health check-up or fever clinic in The Third Affiliated Hospital, Southern Medical University between March 4, 2020 and April 26, 2020. Samples were screened for CoViD-19 infection using the WHO-approved quantitative reverse transcription PCR (RT-qPCR) primers. The positive samples were classified into two groups (high or low) based on viral load in accordance with the CT value of COVID-19 RT-qPCR results. Each positive RNA samples were mixed with COVID-19 negative RNA or ddH2O to form RNA pools. Samples with high viral load could be detected in pool negative samples (up to 1/1000 dilution fold). In contrast, the detection of RNA sample from positive patients with low viral load in a pool was difficult and not repeatable. Our results show that the COVID-19 viral load significantly influences in pooling efficacy. COVID-19 has distinct viral load profile which depends on the timeline of infection. Thus, application of pooling for infection surveillance may lead to false negatives and hamper infection control efforts. *These authors contribute equally to this work. Since it emergence in late 2019, CoViD-19 has dramatically increased the burden healthcare system worldwide. As of April 26, 2020, about 2.8 million diagnosed cases, and 198 thousand confirmed deaths have been reported globally. CoViD-19 is characterized by fever and severe acute respiratory syndrome, which may be accompanied by gastrointestinal and hepatic dysfuntion (1, 2) . Although the number of newly diagnosed cases has been reducing in some parts of the world, the possibility of a second wave of infection has made quick and efficient data gathering essential for policy-making, isolation and treatment of patients. However, it has not been applied for globally for community screening for 2019-nCOV infections. A research team from Stanford University School of Medicine proposed sample "pooling" for tracking of community infection . (6) The authors showed that the sample "pooling" strategy improves the overall detection efficiency and may enhance prevention and control measures. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.18.20106138 doi: medRxiv preprint CoViD-19 infection has two phases (late and early stages); each with a unique viral load profile. To ascertain the efficacy of pooling for tracking 2019-nCOV infections, we build the RNA sample "pooling" strategy which is involving mixing positive RNA sample with low or high viral load with multiple negative RNA samples together. Patients who came for routine medical examination or fever were recruited for the study at the Third Affiliated Hospital of Southern Medical University, Guangzhou City, China. Throat swabs were collected by doctors in fever clinics and isolation wards. The swab was extended into the patient's cavity, wiped around the tonsils and the mucosa of the posterior wall till thoroughly infiltrated. Then, the swab was inserted into a test tube which contained 2 ml of the transport swab buffer mixed with lysis buffer. The samples at 2-8 and delivered to a medical laboratory in 2 hours. Using an RNA extraction kit (Shanghai ZJ Bio-Tech), total RNA was extracted. We obtained swab samples tested between March 4 to April 26, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. Each RNA "pool" was detected using RT-qPCR test as one RNA template. RT-qPCR procedure for individual samples was performed using the same reagent/machine and analyzed using the blind method. Dr. Yichuan Gan mixed the positive RNA sample with negative RNA samples to dilute different ratio. Miss Lingyan Du was responsible for detecting the RNA "pool" using RT-qPCR with unknown of the dilution ratio. Finally, Dr. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.18.20106138 doi: medRxiv preprint Xiaoming Lyu summarised and analyzed the data. The recruitment process, delivery and use of clinic samples obtained from patients who had fever or came for routine medical examination, and the experimental procedures were approved by the Medical Ethics Committee of the Third Affiliated Hospital Of Southern Medical University, Guangzhou, China. The patient Case 1 had a fever with body temperature at 39.3 degrees Celsius ( ), which was accompanied with headache and muscle soreness, and a throat swab sample was collected timely. Case 2 had abdominal pain for two days with l diarrhoea (three to four times each day). The patient also had low-grade fever of 37.3 , and a throat swab sample was collected after a physical examination. They both showed significant positive results of three CoViD-19 probe genes. The positive RNA sample was diluted into 1:2, 1:5, 1:10, 1:20, 1:50, 1:100, 1:250, 1:500, 1:1000 to make RNA "pools". We tested RNA "pools" using RT-qPCR, then found that the positive RNA samples could still be observed in pools of up to 1:1000 ratio, even to 1:8000 diluted in ddH2O with Case 1 (Figure 1A and 1B) . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.18.20106138 doi: medRxiv preprint The patient Case 3 had a fever for a week followed by coughing (with sputum) and sore throat. The body temperature was between 37.1 and 38 . RT-qPCR analysis showed positive result in only two of CoViD-19 probe genes. This positive RNA sample was diluted into the "pool" of one sample to make a 1/2, 1/5, 1/10, 1/20, 1/50, 1/100 dilution. The mixed RNA "pools" were analyzed using the CoViD-19 primers. The positive sample with low viral load could only be observed at a low dilution ratio (which ration; p<0.5) ( Figure 1C ). Each positive RNA sample was diluted with different negative RNA samples (1/2, 1/5, 1/10, 1/20, 1/50). For each dilution ratio, we had ten repeats which was analyzed for the CoViD-19 primer probe. The mixed RNA "pools" formed from the Case 1 and Case 2 samples could be detected each time when the 1/2, 1/5, 1/10, 1/20 RNA pools were used and 90 percent of time when 1/50 ratio RNA pools were used ( Figure. 2A) . In contrast, the positive detection rate in Case 3 was unsatisfactory. As the dilution ratio increase, the detection became negligible ( Figure. 2A ). The long-term curtailment of COVID 19 worldwide depends on quick and efficient monitoring of patients, and affordability of testing in resource-constrained countries. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.18.20106138 doi: medRxiv preprint Currently available commercial assays are efficient; however, they require specialized equipment, which may be limited in supply in the face of the growing need for mass testing. We then carried out COVID-19 qPCR in each reconstituted RNA sample "pools". Our results showed that samples from positive patients with an earlier symptom onset and a higher viral load, could be in RNA "pool" a wide range of dilution folds (ranging from 1/2 to 1/100 with a positive detection rate of p>0.05)) . On the contrary, sample from positive patients with low viral load and late symptom onset could only be detected in RNA "pools" at very low dilution, and the repeatability was unsatisfactory. A number of recent studies have proposed samples pooling for the tracking COVID-19 spread so as to increase testing rate and enhace policy making. In line with recent research, we show . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Each test was carried ten times. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.18.20106138 doi: medRxiv preprint P o s i t iv e i n d i v id u a l 1 P + 1 N 1 P + 4 N 1 P + 9 N 1 P + 1 9 N 1 P + 4 9 N 1 P + 9 9 N 1 P + 1 9 9 N 1 P + 4 9 9 N 1 P + 9 9 9 N A new coronavirus associated with human respiratory disease in China Clinical features of patients infected with 2019 novel coronavirus in Wuhan A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Sample pooling for real-time PCR detection and virulence determination of the footrot pathogen Dichelobacter nodosus Estimating community prevalence of ocular Chlamydia trachomatis infection using pooled polymerase chain reaction testing Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2 SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases